Jul. 12 at 3:58 PM
$DRTS After so many months being one of the most talked about stocks on StockTwits, we now see why. This was always about one thing: Get a piece of the company that is going to rewrite the rule books of solid tumor standard of care.
PMDA cert for Head & neck.
FDA IDEs for: Prostate, Skin, GBM, Pancreatic, and soon to be with Keytruda (
$MRK 's
$32B per year drug)
The hype was not pump & dump. The hype was Pump & Pump. Retail investors that HATE cancer saw that Alpha Tau was destroying solid tumors with a single, brilliant platform and knew institutional investors couldn't get in because the market cap was too low and liquidity was lacking.
And it worked....
Now, Alpha Tau Medical is over
$1B market cap with dramatically larger volumes than just six months ago. Institutional investors, indexes, hedge funds, algos and all others can finally get in on Alpha Tau.
And you can get in with them if you're not already. You won't front run them but you'll have a strong wind in your sails.
